4//SEC Filing
Lapidus Stanley 4
Accession 0001062993-23-018552
CIK 0001799011other
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 8:53 PM ET
Size
9.5 KB
Accession
0001062993-23-018552
Insider Transaction Report
Form 4
Lapidus Stanley
Director
Transactions
- Sale
Common stock
2023-09-26$1.43/sh−10,000$14,300→ 111,339 total - Sale
Common stock
2023-09-26$1.47/sh−10,000$14,740→ 121,339 total - Sale
Common stock
2023-09-25$1.43/sh−200$286→ 131,339 total - Sale
Common stock
2023-09-26$1.45/sh−9,747$14,133→ 101,592 total
Footnotes (3)
- [F1]Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock.
- [F2]Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023.
- [F3]The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023.
Issuer
Lucid Diagnostics Inc.
CIK 0001799011
Entity typeother
Related Parties
1- filerCIK 0001678195
Filing Metadata
- Form type
- 4
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 8:53 PM ET
- Size
- 9.5 KB